Response to Comments: MolDX: Genetic Testing for Heritable Thoracic Aortic Disease

This policy (A60207) is a response-to-comments notice regarding MolDX LCD L39946 and does not present clinical coverage criteria for genetic testing for heritable thoracic aortic disease. The underlying LCD L39946 will enter notice on 2025-07-03 and become effective on 2025-08-17; consult that LCD for specific indications, limitations, documentation requirements, and frequency limits.

"This document is a response to public comments on MolDX LCD L39946 and does not itself contain clinical coverage criteria for genetic testing for heritable thoracic aortic disease."

Sign up to see full coverage criteria, indications, and limitations.